MicroRNA Profiling in Chemoresistant and Chemosensitive Acute Myeloid Leukemia

MicroRNA (miRNA) deregulation is associated with progression and treatment outcome in various types of cancers. To identify miRNAs related to therapeutic response, we applied an miRNA microarray followed by PCR verification of 33 available diagnostic bone marrow core biopsies from 33 acute myeloid leukemia patients including 15 chemoresistant and 18 chemosensitive patients. We found 3 significantly upregulated miRNAs, miR-363, miR-532-5p and miR-342-3p, related to therapeutic response (q < 0.05). Further validation of miR-532-5p and miR-363 expression by quantitative RT-PCR confirmed microarray analysis results. Genes targeted by miR-363 include RGS17 and HIPK3, both reported to be associated with drug response.

[1]  Wei Xu,et al.  Distinctive microRNA signature is associated with the diagnosis and prognosis of acute leukemia , 2012, Medical Oncology.

[2]  I. Georgiou,et al.  miRNAs and related polymorphisms in rheumatoid arthritis susceptibility. , 2012, Autoimmunity reviews.

[3]  S. Knuutila,et al.  MicroRNA profiling in pediatric acute lymphoblastic leukemia: novel prognostic tools , 2012, Leukemia & lymphoma.

[4]  M. Caligiuri,et al.  Up-regulation of a HOXA-PBX3 homeobox-gene signature following down-regulation of miR-181 is associated with adverse prognosis in patients with cytogenetically abnormal AML. , 2012, Blood.

[5]  C. Fan,et al.  Suppression of Breast Tumor Growth and Metastasis by an Engineered Transcription Factor , 2011, PloS one.

[6]  S. Knuutila,et al.  Integrative analysis of microRNA, mRNA and aCGH data reveals asbestos‐ and histology‐related changes in lung cancer , 2011, Genes, chromosomes & cancer.

[7]  Noam Shomron,et al.  MicroRNA pharmacogenomics: post-transcriptional regulation of drug response. , 2011, Trends in molecular medicine.

[8]  M. Tschan,et al.  Deregulated expression of Kruppel-like factors in acute myeloid leukemia. , 2011, Leukemia research.

[9]  Elizabeth E. Hoskins,et al.  Alteration of microRNA profiles in squamous cell carcinoma of the head and neck cell lines by human papillomavirus , 2011, Head & neck.

[10]  Shuqiang Li,et al.  MicroRNA Expression Profiling Identifies Activated B Cell Status in Chronic Lymphocytic Leukemia Cells , 2011, PloS one.

[11]  S. Knuutila,et al.  MicroRNA microarrays on archive bone marrow core biopsies of leukemias--method validation. , 2011, Leukemia research.

[12]  Mandi M. Murph,et al.  Regulators of G-Protein signaling RGS10 and RGS17 regulate chemoresistance in ovarian cancer cells , 2010, Molecular Cancer.

[13]  S. Knuutila,et al.  Unique microRNA profile in Dupuytren's contracture supports deregulation of β-catenin pathway , 2010, Modern Pathology.

[14]  Jian-yong Li,et al.  [Detection of miRNA levels in leukemia patients by real-time quantitative PCR]. , 2010, Zhongguo shi yan xue ye xue za zhi.

[15]  Sung-Liang Yu,et al.  A Four-Gene Signature from NCI-60 Cell Line for Survival Prediction in Non–Small Cell Lung Cancer , 2009, Clinical Cancer Research.

[16]  F. Lo‐Coco,et al.  A restricted signature of miRNAs distinguishes APL blasts from normal promyelocytes , 2009, Oncogene.

[17]  M. Sim,et al.  Regulation of RUNX3 Tumor Suppressor Gene Expression in Cutaneous Melanoma , 2009, Clinical Cancer Research.

[18]  P. Dickman,et al.  Improved patient survival for acute myeloid leukemia: a population-based study of 9729 patients diagnosed in Sweden between 1973 and 2005. , 2009, Blood.

[19]  A. Neri,et al.  Bmc Medical Genomics an Integrative Genomic Approach Reveals Coordinated Expression of Intronic Mir-335, Mir-342, and Mir-561 with Deregulated Host Genes in Multiple Myeloma , 2008 .

[20]  M. Caligiuri,et al.  MicroRNA expression in cytogenetically normal acute myeloid leukemia. , 2008, The New England journal of medicine.

[21]  R. Zini,et al.  MicroRNA expression profile in granulocytes from primary myelofibrosis patients. , 2007, Experimental hematology.

[22]  E. Kistner,et al.  Let-7 expression defines two differentiation stages of cancer , 2007, Proceedings of the National Academy of Sciences.

[23]  G. Lutz,et al.  Nanopolymers improve delivery of exon skipping oligonucleotides and concomitant dystrophin expression in skeletal muscle of mdx mice , 2008, BMC biotechnology.

[24]  C. Croce,et al.  MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemia , 2007, Oncogene.

[25]  Meng Ling Choong,et al.  MicroRNA expression profiling during human cord blood-derived CD34 cell erythropoiesis. , 2007, Experimental hematology.

[26]  C. Croce,et al.  MicroRNA signatures in human cancers , 2006, Nature Reviews Cancer.

[27]  F. Slack,et al.  Oncomirs — microRNAs with a role in cancer , 2006, Nature Reviews Cancer.

[28]  T. Cotter,et al.  JNK Regulates HIPK3 Expression and Promotes Resistance to Fas-mediated Apoptosis in DU 145 Prostate Carcinoma Cells* , 2004, Journal of Biological Chemistry.

[29]  G. Calin,et al.  Non-coding RNAs for medical practice in oncology. , 2011, The Keio journal of medicine.